View All United States Tuberculosis Datasets

• Forecast: Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of Incident Tuberculosis Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of Notified Tuberculosis Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Mortality in the US

  • Units (Male Deaths) Per Hundred Thousand Men, Standardised Rates
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Mortality in the US

  • Units (Deaths) Per Hundred Thousand Persons, Standardised Rates
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of New Clinically Diagnosed Pulmonary Tuberculosis Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of Multidrug-Resistant Tuberculosis Cases Started on a Treatment in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Death Rate in the US

  • Units (Deaths) Per Hundred Thousand Persons
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Incidence of Tuberculosis in the US

  • Units (Cases) Per Hundred Thousand Persons
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Mortality in the US

  • Units (Female Deaths) Per Hundred Thousand Women, Standardised Rates
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Mortality in the US

  • Units (Male Deaths)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of Prevalent Tuberculosis Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Mortality in the US

  • Units (Deaths) Per Hundred Thousand Persons
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of New Clinically Diagnosed Pulmonary Tuberculosis Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of New Extrapulmonary Tuberculosis Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of Multidrug-Resistant Tuberculosis Cases Started on a Treatment in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis in the US

  • Percent
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Treatment Success Rate for Previously Treated Cases in the US

  • Percent
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Treatment Success Rate for Newly Treated Cases in the US

  • Percent
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Mortality in the US

  • Units (Female Deaths)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Prevalence in the US

  • Units (Cases) Per Hundred Thousand Persons
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of New and Relapse Tuberculosis Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of New Extrapulmonary Tuberculosis Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis in the US

  • Percent
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of New Bacteriologically Confirmed Pulmonary Tuberculosis Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of Incident Tuberculosis Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Mortality in the US

  • Units (Male Deaths) Per Hundred Thousand Men
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Treatment Success Rate for Previously Treated Cases in the US

  • Percent
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of Prevalent Tuberculosis Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of Notified Tuberculosis Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Prevalence in the US

  • Units (Cases) Per Hundred Thousand Persons
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Treatment Success Rate in the US

  • Percent of New Cases
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of New Bacteriologically Confirmed Pulmonary Tuberculosis Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Mortality in the US

  • Units (Female Deaths) Per Hundred Thousand Women
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Mortality in the US

  • Units (Deaths)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Tuberculosis Treatment Success Rate for Newly Treated Cases in the US

  • Percent
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Number of New and Relapse Tuberculosis Cases in the US

  • Units (Cases)
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Total Tuberculosis Incidence Rate in the US

  • Ratios
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis in the US

  • Percent
  • 2024 to 2028
  • ReportLinker Research